| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.30B | +3.0% |
| R&D Expense | $6.0M | +0.0% |
| SG&A Expense | $568.0M | -11.0% |
| Operating Income | $1.16B | +5.1% |
| Pre-tax Income | $1.33B | +8.6% |
| Income Tax | $356.0M | +8.2% |
| Net Income | $911.0M | +10.2% |
| EPS (Basic) | $2.34 | +17.6% |
| EPS (Diluted) | $2.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $723.0M | -35.9% |
| Short-term Investments | $1.12B | -23.8% |
| Accounts Receivable | $79.0M | +16.2% |
| Inventory | $405.0M | -4.5% |
| Current Assets | $2.69B | -21.5% |
| Total Assets | $11.12B | -7.6% |
| Current Liabilities | $2.28B | -5.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.42B | -3.7% |
| Capital Expenditures | $705.0M | -0.7% |
| Investing Cash Flow | -$178.0M | +76.0% |
| Financing Cash Flow | -$1.64B | -128.5% |
| Free Cash Flow | $714.0M | -6.4% |
| +18.3% |
| Total Liabilities |
| $4.69B |
| -4.4% |
| Stockholders' Equity | $5.73B | -10.6% |